Bismuth-213 for Targeted Radionuclide Therapy: From Atom to Bedside

Bismuth-213 for Targeted Radionuclide Therapy: From Atom to Bedside

In contrast to external high energy photon or proton therapy, targeted radionuclide therapy (TRNT) is a systemic cancer treatment allowing targeted irradiation of a primary tumor and all its metastases, resulting in less collateral damage to normal tissues. The α-emitting radionuclide bismuth-213 (&...

Full description

Bibliographic Details
Main Authors:	Stephen Ahenkorah, Irwin Cassells, Christophe M. Deroose, Thomas Cardinaels, Andrew R. Burgoyne, Guy Bormans, Maarten Ooms, Frederik Cleeren
Format:	Article
Language:	English
Published:	MDPI AG 2021-04-01
Series:	Pharmaceutics
Subjects:	bismuth-213 targeted radionuclide therapy targeted alpha therapy radiopharmaceutical bifunctional chelator vector molecule
Online Access:	https://www.mdpi.com/1999-4923/13/5/599

Similar Items

Targeted Alpha Therapy: Progress in Radionuclide Production, Radiochemistry, and Applications
by: Bryce J. B. Nelson, et al.
Published: (2020-12-01)

What is the role of the bystander response in radionuclide therapies?
by: Darren eBrady, et al.
Published: (2013-08-01)

Subcellular Targeting of Theranostic Radionuclides
by: Bas M. Bavelaar, et al.
Published: (2018-09-01)

Peptides in receptor-mediated radiotherapy : from design to the clinical application in cancers.
by: Catherine eLOZZA, et al.
Published: (2013-09-01)

Overview of the Most Promising Radionuclides for Targeted Alpha Therapy: The “Hopeful Eight”
by: Romain Eychenne, et al.
Published: (2021-06-01)

Efficient formation of inert Bi-213 chelates by tetraphosphorus acid analogues of DOTA: towards improved alpha-therapeutics
by: Jakub Šimeček, et al.
Published: (2018-08-01)

Gamma counting protocols for the accurate quantification of 225Ac and 213Bi without the need for a secular equilibrium between parent and gamma-emitting daughter
by: Dayana Castillo Seoane, et al.
Published: (2022-10-01)

The Chemical Scaffold of Theranostic Radiopharmaceuticals: Radionuclide, Bifunctional Chelator, and Pharmacokinetics Modifying Linker
by: Holis Abdul Holik, et al.
Published: (2022-05-01)

Bifunctional gallium cation chelators
by: A. G. Polivanova, et al.
Published: (2022-06-01)

Optimizing the Safety and Efficacy of Bio-Radiopharmaceuticals for Cancer Therapy
by: Cyprine Neba Funeh, et al.
Published: (2023-04-01)

Advances in macrocyclic chelators for positron emission tomography imaging
by: Mengting Li, et al.
Published: (2023-10-01)

Optimizing labelling conditions of 213Bi-DOTATATE for preclinical applications of peptide receptor targeted alpha therapy
by: Ho Sze Chan, et al.
Published: (2016-05-01)

Treatment with Radiopharmaceuticals and Radionuclides in Breast Cancer: Current Options
by: Burcu Altıparmak Güleç, et al.
Published: (2021-07-01)

Corrosion behavior of iron-chrome alloys in liquid bismuth
by: Toshihide TAKAI, et al.
Published: (2022-08-01)

Radionuclides for Targeted Therapy: Physical Properties
by: Caroline Stokke, et al.
Published: (2022-08-01)

Determinants of target absorbed dose in radionuclide therapy
by: Heribert Hänscheid, et al.
Published: (2023-02-01)

Combination Therapy, a Promising Approach to Enhance the Efficacy of Radionuclide and Targeted Radionuclide Therapy of Prostate and Breast Cancer
by: Tyrillshall S. T. Damiana, et al.
Published: (2021-05-01)

A Radionuclide Generator of High-Purity Bi-213 for Instant Labeling
by: Stanislav Ermolaev, et al.
Published: (2021-06-01)

Development of a methodology for the analysis of radionuclide impurities in radiopharmaceuticals by gamma-ray spectrometry
by: Eduardo Bonfim De Paula, et al.
Published: (2017-11-01)

Modern Developments in Bifunctional Chelator Design for Gallium Radiopharmaceuticals
by: Patrick R. W. J. Davey, et al.
Published: (2022-12-01)

Radiopharmaceuticals: From Molecular Imaging to Targeted Radionuclide Therapy
by: P. August Schubiger, et al.
Published: (2004-10-01)

Recent Innovations and Nano-Delivery of Actinium-225: A Narrative Review
by: Sipho Mdanda, et al.
Published: (2023-06-01)

Long-Term Tumor Control Following Targeted Alpha Therapy (TAT) of Low-Grade Gliomas (LGGs): A New Treatment Paradigm?
by: Leszek Krolicki, et al.
Published: (2023-10-01)

Synthesis and Biological Evaluation of <sup>99m</sup>Tc(I) Tricarbonyl Complexes Dual-Targeted at Tumoral Mitochondria
by: Diogo Figueiredo, et al.
Published: (2021-01-01)

Targeted Radiotherapeutics from 'Bench-to-Bedside'
by: Cristina Müller, et al.
Published: (2020-12-01)

AAZTA-Derived Chelators for the Design of Innovative Radiopharmaceuticals with Theranostic Applications
by: Cyril Fersing, et al.
Published: (2022-02-01)

Clinical Advances and Perspectives in Targeted Radionuclide Therapy
by: Nicolas Lepareur, et al.
Published: (2023-06-01)

Radionuclide Delivery Strategies in Tumor Treatment: A Systematic Review
by: Giulia Poletto, et al.
Published: (2022-07-01)

Approach to radionuclide therapy dosimetry planning
by: Yu.V. Lysak, et al.
Published: (2016-12-01)

Single-dose anti-CD138 radioimmunotherapy: bismuth-213 is more efficient than lutetium-177 for treatment of multiple myeloma in a preclinical model
by: Nolwenn eFichou, et al.
Published: (2015-11-01)

Targeted Radionuclide Therapy
by: David Cheng, et al.
Published: (2011-10-01)

Radiochemical Synthesis and Evaluation of Novel Radioconjugates of Neurokinin 1 Receptor Antagonist Aprepitant Dedicated for NK1R-Positive Tumors
by: Paweł K. Halik, et al.
Published: (2020-08-01)

Advances in Targeted Alpha Therapy: Preparation and Separation of Alpha Radionuclides
by: WANG Lu-sheng, et al.
Published: (2022-06-01)

Peptide Receptor Radionuclide Therapy and Primary Brain Tumors: An Overview
by: Andrea Cimini, et al.
Published: (2021-08-01)

Targeting Melanin in Melanoma with Radionuclide Therapy
by: Kevin J. H. Allen, et al.
Published: (2022-08-01)

Therapeutic Radiometals: Worldwide Scientific Literature Trend Analysis (2008–2018)
by: Licia Uccelli, et al.
Published: (2019-02-01)

Dual targeting with 224Ra/212Pb-conjugates for targeted alpha therapy of disseminated cancers: A conceptual approach
by: Asta Juzeniene, et al.
Published: (2023-01-01)

The Current Role of Peptide Receptor Radionuclide Therapy in Meningiomas
by: Christina-Katharina Fodi, et al.
Published: (2022-04-01)

Comparative Radioimmunotherapy of Experimental Melanoma with Novel Humanized Antibody to Melanin Labeled with 213Bismuth and 177Lutetium
by: Kevin J. H. Allen, et al.
Published: (2019-07-01)

Exploring the Application of Bifunctional Metal Chelators in Treating Triple-Negative Breast Cancer
by: Kuo Li, et al.
Published: (2021-08-01)